Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

David M. Sabatini(Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry), Alejo Efeyan(Spanish National Cancer Research Centre), Rachel L. Wolfson(Broad Institute)
DSpace@MIT (Massachusetts Institute of Technology)
December 1, 2015
Cited by 0

Related Papers

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
mTOR: from growth signal integration to cancer, diabetes and ageing
|Nature Reviews Molecular Cell Biology|2010|4k
mTOR signaling at a glance
|Journal of Cell Science|2009|2.1k
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
|Nature|2011|1.7k
mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H <sup>+</sup> -ATPase
|Science|2011|1.6k